Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:ageRange |
18 years and older
|
| gptkbp:allocates |
Randomized
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:completedIn |
December 2011
|
| gptkbp:condition |
Metastatic Colorectal Cancer
|
| gptkbp:enrollment |
471
|
| gptkbp:gender |
All
|
| https://www.w3.org/2000/01/rdf-schema#label |
NCT00593450
|
| gptkbp:intervention |
gptkb:Bevacizumab
Chemotherapy |
| gptkbp:location |
International (multiple countries)
|
| gptkbp:mask |
Open Label
|
| gptkbp:purpose |
Treatment
|
| gptkbp:result |
Progression-free survival
|
| gptkbp:secondaryOutcome |
Safety
Overall survival Duration of response Objective response rate |
| gptkbp:sponsor |
gptkb:Hoffmann-La_Roche
|
| gptkbp:startDate |
January 2008
|
| gptkbp:status |
completed
|
| gptkbp:studyType |
Interventional
|
| gptkbp:title |
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
|
| gptkbp:bfsParent |
gptkb:Comparison_of_Age-related_macular_degeneration_Treatments_Trials
|
| gptkbp:bfsLayer |
8
|